| abstract |
Methods and compositions comprising hogocidin peptides (SH-lantibiotic), derivatives and variants are provided. Also provided are methods, including probiotic compositions and methods utilizing Staphylococcus hominis and Staphylococcus epidermidis strains that produce hogosidine, hogosidine-like peptides or other inhibitors of skin pathogens. Also provided are methods of treating microbial skin infections and atopic dermatitis. [Selection] Figure 1A-B |